Article
Juvenile myelomonocytic leukemia - A bona fide RASopathy syndrome.
Best practice & research. Clinical haematology - 1 Jun 2020
Lasho Terra, Patnaik Mrinal M
Abstract excerpt
Juvenile myelomonocytic leukemia (JMML) is a pediatric myelodysplastic/myeloproliferative neoplasm overlap syndrome with sustained peripheral blood monocytosis, aggressive features, and poor outcomes. In >90% of cases JMML is driven by germline or somatic mutations involving the canonical RAS pathway (PTPN11, NRAS, CBL, KRAS and NF1), with somatic mutations/alterations in RAS pathway genes (second hit), SETBP1,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
